Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shixia Huang

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
JCI Insight|September 10, 2024
Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancerKarthik Reddy Kami Reddy, Danthasinghe Waduge Badrajee Piyarathna, Jun Hyoung Park, et al.
The Journal of Clinical Investigation|June 17, 2024
The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defectRonit Marom, I-Wen Song, Emily C Busse, et al.
Cancer Research|February 24, 2018
Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast CancersFilip Mundt, Sandeep Rajput, Shunqiang Li, et al.
Nature Communications|May 20, 2016
Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancerAkash K Kaushik, Ali Shojaie, Katrin Panzitt, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
JCI Insight|September 10, 2024
Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancerKarthik Reddy Kami Reddy, Danthasinghe Waduge Badrajee Piyarathna, Jun Hyoung Park, et al.
The Journal of Clinical Investigation|June 17, 2024
The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defectRonit Marom, I-Wen Song, Emily C Busse, et al.
Cancer Research|February 24, 2018
Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast CancersFilip Mundt, Sandeep Rajput, Shunqiang Li, et al.
Nature Communications|May 20, 2016
Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancerAkash K Kaushik, Ali Shojaie, Katrin Panzitt, et al.
Pageof 10